about
Confocal laser scanning microscopy for detection of Schistosoma mansoni eggs in the gut of miceSafety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.Single-sex infection with female Schistosoma mansoni cercariae mitigates hepatic fibrosis after secondary infectionTick-borne encephalitis virus habitats in North East Germany: reemergence of TBEV in ticks after 15 years of inactivity.Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.Biosensor for Hepatocellular Injury Corresponds to Experimental Scoring of Hepatosplenic Schistosomiasis in Mice.Multiple sclerosis treatment and infectious issues: update 2013.Reducing the underreporting of percutaneous exposure incidents: A single-center experience.Bilateral upper arm swelling and weight loss.Schistosoma mansoni: schistosomicidal effect of mefloquine and primaquine in vitro.Pneumocystis jirovecii colonisation in HIV-positive and HIV-negative subjects in Cameroon.Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience.Serum fatty acids, antioxidants, and treatment response in hepatitis C infection: greater polyunsaturated fatty acid and antioxidant levels in hepatitis C responders.Borrelia burgdorferi and Anaplasma phagocytophilum coinfection.Tenofovir for treatment of hepatitis B virus reactivation in patients with chronic GVHD.A case of acute hepatitis A infection in an HIV-positive patient despite complete hepatitis A vaccination.Health problems and behavioural risks in travellers to the tropics - A commentary.Host Defense Versus Immunosuppression: Unisexual Infection With Male or Female Schistosoma mansoni Differentially Impacts the Immune Response Against Invading Cercariae.A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adultsImmunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial[Mosquitoes and Ticks: The Influence of Global Warming in the Transmission of Infectious Diseases in Germany]Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapiesAccidental intrathecal administration of bleomycin: favorable outcome after pneumo-encephalus and cerebrospinal fluid exchange: a case reportFingolimod treatment for multiple sclerosis patients What do we do with varicella?It began with a suspected abscessVector-mediated microRNA-21 silencing ameliorates granulomatous liver fibrosis in Schistosoma japonicum infectionAmpicillin/sulbactam in elderly patients with community-acquired pneumoniaDoes medical education predispose to risk behaviour during travel?Immune response to hepatitis A vaccine in patients with HIVTick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter study
P50
Q27347265-DF4453DD-665D-4278-A8A2-F6C6893D1E4CQ30397594-3FFBBC01-C6A5-46ED-8455-D69294F1D20BQ33752060-B04E2FDB-7C1C-4178-8720-9336AAE2E9FBQ33943284-E5D5EBC4-1CF0-46E1-84DC-300BBD52E5F9Q34970364-4A6CF147-4031-4500-9610-047B585E0924Q35201779-24F14F22-CCEF-4A8C-BF2C-8DD87F466F33Q37027056-B30C3E0D-C2B5-43FE-A1A3-2789AB604D53Q38153471-5DA6A8E0-45B3-4D6E-9E0B-7A757C9DA391Q39012795-08FE124F-643E-42AD-A9E6-740F2E500D2CQ39012814-CD77F250-8544-4107-9516-E63701691DE3Q39074551-07F1A646-230B-460A-8469-70187F05C2BFQ39398078-5E179136-D40B-4FBC-B4D4-5C0424011AEDQ41733873-9FF584F3-02CE-47E3-BD23-C103C94EC4C5Q43038960-7FF3E395-E586-4FA6-8CE1-121CECD22FA6Q43196253-5749A059-9502-4432-86CD-20D8010210E5Q45370522-6E856431-7915-4499-8F96-C6865AF07BC6Q52726439-A856B74B-4E1E-4A80-909C-25C46822E5EEQ53789400-913EEDEF-C8B2-4605-B956-40C2D6272A7FQ55311783-B6E165FD-C9D7-4F13-938A-6491ED24CFD7Q57294470-F721F071-3EAB-4D18-BB8B-C3C4CA49B0FDQ58611177-8AB54DE5-6610-4DE8-92C4-5FAE3A9CC900Q59245658-B6763862-FB32-4FD0-B853-8EDB885A6C94Q59356051-DC0D3BD6-0D2D-4E37-9AEA-AEFA3BE2332BQ80376922-5FA1269D-9E50-41A2-BD99-8B2C9849E200Q82209838-54C4CE46-CB8C-4BAC-8CFC-20E3C4FC8D73Q82653964-4F191066-4BD3-4128-B0C7-071D08060C6CQ86743127-1695E54A-F899-4E8C-9281-0122EA5C73C8Q87176799-63E0D237-1762-40F8-9A94-0E68DAB3DE77Q88651576-17864048-D271-4FF2-AF1D-36C6059A8690Q92486155-CD01DA08-3597-4205-B0E5-214B65D97231Q92526756-D1F9A2E9-128B-46A7-95CA-50AB024CC627
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
M Loebermann
@ast
M Loebermann
@en
M Loebermann
@es
M Loebermann
@nl
M Loebermann
@sl
type
label
M Loebermann
@ast
M Loebermann
@en
M Loebermann
@es
M Loebermann
@nl
M Loebermann
@sl
prefLabel
M Loebermann
@ast
M Loebermann
@en
M Loebermann
@es
M Loebermann
@nl
M Loebermann
@sl
P214
P106
P1153
6507856768
P214
P31
P496
0000-0002-3453-8998
P7859
viaf-40306404